Therapeutic targets : modulation, inhibition, and activation
著者
書誌事項
Therapeutic targets : modulation, inhibition, and activation
John Wiley & Sons, c2012
大学図書館所蔵 全2件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes bibliographical references and index
内容説明・目次
内容説明
The Latest Applications For Cellmechanism Research in Drug Discovery
Designed to connect research on cell mechanisms with the drug discovery process, Therapeutic Targets: Modulation, Inhibition, and Activation introduces readers to a range of new concepts and novel approaches to drug screening and therapeutic drug targeting to help inform future avenues of drug research. Highly topical, this accessible edited volume features chapters contributed by respected experts from around the globe.
The book helps postgraduate students and professional scientists working in academia and industry understand the molecular mechanisms of pharmacology, current pharmacological knowledge, and future perspectives in drug discovery, focusing on important biochemical protein targets and drug targeting strategies for specific diseases. Examining the pharmacology of therapeutically undefined targets and their potential applications, it includes chapters on traditional therapeutic targets, including enzymes (phosphodiesterases and proteases), ion channels, and G protein-coupled receptors, as well as more recently identified avenues of exploration, such as lipids, nuclear receptors, gene promoters, and more.
Since different diseases require different targeting techniques, the book also includes dedicated chapters on strategies for investigating Alzheimer's, diabetes, pain, and inflammation treatments. Concluding with a cross-sectional look at new approaches in drug screening, Therapeutic Targets is an invaluable resource for understanding where the next generation of drugs are likely to emerge.
目次
Preface vii
Contributors ix
1. cAMP-Specific Phosphodiesterases: Modulation, Inhibition, and Activation 1
R. T. Cameron and George S. Baillie
2. Protease-Activated Receptor 2 37
Qihai Gu and Lu-Yuan Lee
3. Voltage-Gated Sodium Channels as Therapeutic Targets 63
Joshua S. Wingerd, Irina Vetter, and Richard J. Lewis
4. Multitarget Drugs for Stabilization of Calcium Cycling and Neuroprotection in Neurodegenerative Diseases and Stroke 123
Antonio M. G. de Diego, Silvia Lorrio, Jesus M. Hernandez-Guijo, Luis Gandia, and Antonio G. Garcia
5. Oligomerization of G-Protein-Coupled Receptors 201
Juan F. Lopez-Gimenez and Javier Gonzalez-Maeso
6. Sigma 1 Receptor Chaperone: Pharmacology and Therapeutic Perspectives 225
Daniel Zamanillo, Enrique Portillo-Salido, Jose Miguel Vela, and Luz Romero
7. Lipids as New Targets 279
Eduardo Domunguez
8. Knowledge Base for Nuclear Receptor Drug Discovery 309
Albert A. Antolin and Jordi Mestres
9. Gene Promoters and Transcription Control Regions as Therapeutic Targets 327
Antonio Zorzano, David Sebastian, Jana Sanchez-Wandelmer, Laia Miret, and Fernando Albericio
10. Roles of Glucagon-Like Peptide and Glucose-Dependent Insolinotropic Polypeptide Hormones in Brain Function and Neurodegeneration 351
Christian Hoelscher
11. Exocytotic Machinery as a Target for the Development of New Drugs for Schizophrenia 375
Maria Jose Guerrero, Itsaso Hormaeche, Maria Uribarri, Julie Masse, and Jose Maria Palacios
12. Targeting Epigenetic Abnormalities in the Brain 409
Erin Y. Sterner, Lisa E. Kalynchuk, and Hector J. Caruncho
13. Rodent Models as Tools for Discovering Novel Therapeutic Targets in the Brain: The Case of Epilepsy 427
Justin J. Botterill, Axel J. Guskjolen, Lisa E. Kalynchuk, and Hector J. Caruncho
14. New Approaches Applied to Drug Screening 455
Jose Brea and Maria Isabel Loza
Index 477
「Nielsen BookData」 より